Your browser is no longer supported. Please, upgrade your browser.
Settings
CERS Cerus Corporation daily Stock Chart
CERS [NASD]
Cerus Corporation
Index- P/E- EPS (ttm)-0.42 Insider Own0.50% Shs Outstand137.08M Perf Week10.60%
Market Cap886.91M Forward P/E- EPS next Y-0.36 Insider Trans-18.16% Shs Float133.03M Perf Month14.11%
Income-52.80M PEG- EPS next Q-0.11 Inst Own65.70% Short Float2.82% Perf Quarter22.08%
Sales74.40M P/S11.92 EPS this Y9.40% Inst Trans3.70% Short Ratio4.70 Perf Half Y-9.64%
Book/sh0.68 P/B9.51 EPS next Y16.30% ROA-38.00% Target Price8.88 Perf Year56.66%
Cash/sh0.87 P/C7.45 EPS next 5Y- ROE-68.90% 52W Range4.00 - 8.05 Perf YTD27.61%
Dividend- P/FCF- EPS past 5Y-13.90% ROI-89.40% 52W High-19.63% Beta1.43
Dividend %- Quick Ratio3.20 Sales past 5Y6.90% Gross Margin56.60% 52W Low61.75% ATR0.20
Employees215 Current Ratio3.50 Sales Q/Q47.30% Oper. Margin-67.70% RSI (14)67.56 Volatility4.15% 3.38%
OptionableYes Debt/Eq0.32 EPS Q/Q13.50% Profit Margin-71.00% Rel Volume0.76 Prev Close6.25
ShortableYes LT Debt/Eq0.26 EarningsMar 07 AMC Payout- Avg Volume798.75K Price6.47
Recom- SMA2010.33% SMA5015.80% SMA2000.96% Volume609,268 Change3.52%
Jan-05-18Resumed Cantor Fitzgerald Overweight
Dec-08-17Resumed BTIG Research Neutral
Jul-07-16Resumed Cantor Fitzgerald Buy $9
Dec-17-15Downgrade Wedbush Outperform → Neutral
May-02-14Reiterated MLV & Co Buy $8.50 → $6
Apr-24-13Reiterated Cantor Fitzgerald Buy $5.50 → $6
Mar-15-13Reiterated MLV & Co Buy $7.50 → $8.50
Apr-17-12Initiated Cantor Fitzgerald Buy $5.50
Feb-29-12Upgrade Robert W. Baird Neutral → Outperform $3 → $6
Nov-10-11Reiterated MLV & Co Buy $4 → $5
Jun-03-11Initiated Wedbush Outperform $4
Mar-04-11Downgrade Robert W. Baird Outperform → Neutral $4 → $3
Mar-09-10Upgrade Robert W. Baird Neutral → Outperform $3 → $5
Aug-26-09Upgrade Avondale Mkt Perform → Mkt Outperform $2 → $5
Jul-28-09Downgrade Robert W. Baird Outperform → Neutral $3
May-04-09Downgrade JMP Securities Mkt Perform → Mkt Underperform
Feb-27-09Downgrade Avondale Mkt Outperform → Mkt Perform
May-02-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-29-08Initiated JMP Securities Mkt Outperform
Dec-05-07Initiated Susquehanna Financial Neutral
Feb-14-19 07:20AM  Consolidated Research: 2019 Summary Expectations for Varonis, Dolby Laboratories, Alder BioPharmaceuticals, Retail Properties of America, Cerus, and Motorcar Parts of America Fundamental Analysis, Key Performance Indications GlobeNewswire
Feb-13-19 08:30AM  Cerus to Release Fourth Quarter and Full Year 2018 Results on February 26, 2019 Business Wire
Jan-16-19 11:00AM  How Should Investors React To Cerus Corporations (NASDAQ:CERS) CEO Pay? Simply Wall St.
Jan-07-19 08:30AM  Cerus Announces Preliminary Fourth Quarter and Full Year 2018 Product Revenue Business Wire
Jan-04-19 08:30AM  William Moore Appointed as Cerus Corporations Senior Vice President of Manufacturing Operations and Supply Chain Business Wire
Dec-19-18 08:30AM  Cerus Announces First Patient Enrolled in the Phase 3 ReCePI Study Business Wire
Dec-18-18 08:30AM  Cerus Completes CE Mark Submission for INTERCEPT Red Blood Cells Business Wire
02:14AM  Do Hedge Funds Love Cerus Corporation (CERS)? Insider Monkey
Dec-17-18 10:39AM  What Investors Should Know About Cerus Corporations (NASDAQ:CERS) Financial Strength Simply Wall St.
Dec-10-18 08:30AM  American Red Cross Receives Biologics License Application Approval For INTERCEPT Platelets Business Wire
Dec-04-18 05:00PM  Cerus Supports FDAs Continuing Efforts to Enhance the Safety of the U.S. Platelet Supply Business Wire
Nov-15-18 10:48AM  Does Cerus Corporation (NASDAQ:CERS) Have A Particularly Volatile Share Price? Simply Wall St.
Nov-12-18 07:20AM  Report: Developing Opportunities within Lexicon Pharmaceuticals, Cray, RCI Hospitality, Sanmina, Diamond Offshore Drilling, and Cerus Future Expectations, Projections Moving into 2018 GlobeNewswire -8.03%
Nov-09-18 08:30AM  Cerus to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-08-18 07:19PM  Edited Transcript of CERS earnings conference call or presentation 1-Nov-18 8:15pm GMT Thomson Reuters StreetEvents
Nov-02-18 08:30AM  Cerus to Present at the 2018 Stephens NY Investment Conference Business Wire -5.91%
Nov-01-18 05:25PM  Cerus: 3Q Earnings Snapshot Associated Press
04:01PM  Cerus Corporation Reports Third Quarter 2018 Results Business Wire
Oct-31-18 08:30AM  Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate Business Wire +6.52%
Oct-23-18 08:30AM  Cerus to Release Third Quarter 2018 Results on November 1, 2018 Business Wire
Oct-18-18 08:10AM  Detailed Research: Economic Perspectives on Cerus, AdvanSix, Spark Therapeutics, Imperva, Central Garden & Pet, and Francesca's What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-16-18 03:01PM  Here's Why Cerus Corporation Stock Popped Today Motley Fool +15.44%
08:30AM  Cerus to Provide Update to Development Programs and Outline Growth Strategy at 2018 Institutional Investor Meeting Business Wire
Oct-12-18 08:30AM  Cerus Announces Schedule of Presentations at the 2018 AABB Annual Meeting Business Wire
Oct-11-18 08:30AM  Dr. Laurence Corash Recognized With the Prestigious Dale A. Smith Memorial Award Business Wire
Oct-10-18 11:28AM  Cerus Corporations (NASDAQ:CERS) Most Important Factor To Consider Simply Wall St. -5.03%
Oct-09-18 04:05PM  Cerus Appoints Eric Bjerkholt to Board of Directors Business Wire
Oct-02-18 08:30AM  Cerus to Host Institutional Investor Meeting Business Wire
Sep-26-18 08:30AM  Cerus to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference Business Wire
Sep-06-18 04:15PM  Cerus Appoints Timothy L. Moore to Board of Directors Business Wire
Sep-04-18 11:11AM  Cerus Corporation (NASDAQ:CERS): Is Now The Time To Bet On Healthcare? Simply Wall St.
Aug-28-18 08:15AM  New Research Coverage Highlights Evertec, Cerus, REV Group, U.S. Silica, The Manitowoc, and World Fuel Services Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-13-18 11:34PM  Edited Transcript of CERS earnings conference call or presentation 2-Aug-18 8:15pm GMT Thomson Reuters StreetEvents
Aug-06-18 07:30AM  Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates (Revised) Zacks
Aug-02-18 06:20PM  Cerus (CERS) Reports Q2 Loss, Misses Revenue Estimates Zacks
05:13PM  Cerus: 2Q Earnings Snapshot Associated Press
04:03PM  Cerus Corporation Reports Second Quarter 2018 Results Business Wire
02:15PM  Cerus Corporation to Host Earnings Call ACCESSWIRE
Jul-31-18 07:15AM  Free Stock Performance Review on Biogen and Three Additional Biotech Stocks ACCESSWIRE
Jul-30-18 07:26AM  Zacks.com featured highlights include: OFG, Northern Oil, Sunrun, Cerus and Veracyte Zacks
Jul-27-18 08:41AM  5 Breakout Stocks Offering Stellar Returns Zacks
Jul-19-18 08:30AM  Cerus to Release Second Quarter 2018 Results on August 2, 2018 Business Wire
Jul-10-18 08:30AM  New Navy Policy Implements Full Adoption of Pathogen-Reduced Apheresis Platelets Collected at U.S. Navy Blood Donor Centers Business Wire
Jun-28-18 08:25AM  Report: Developing Opportunities within Torchmark, Cerus, American Equity Investment Life Holding, Southern Copper, F5 Networks, and Diebold Nixdorf Future Expectations, Projections Moving into 2018 GlobeNewswire
07:20AM  Free Technical Reports on Cerus and Three Additional Biotech Equities ACCESSWIRE
Jun-25-18 08:20AM  Cerus Corporation Sees Product Demand Double, Revises Guidance Upward ACCESSWIRE
Jun-15-18 11:30AM  Cerus Presents Results of European Phase 3 Chronic Anemia Study at the 23rd Congress of European Hematology Association Business Wire
Jun-01-18 08:30AM  Cerus Announces Presentations Highlighting INTERCEPT Blood Systems at the 35th International Congress of the International Society of Blood Transfusion Business Wire
May-18-18 07:05AM  Audentes Therapeutics and Three More Stocks Under Scanner in the Biotech Space ACCESSWIRE
May-16-18 05:15PM  Cerus Announces Additional BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells Business Wire
May-15-18 08:20AM  New Research Coverage Highlights Cerus, Health Insurance Innovations, Tetra Tech, Ferro, Dril-Quip, and MSC Industrial Direct Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
May-11-18 11:46PM  Edited Transcript of CERS earnings conference call or presentation 8-May-18 8:15pm GMT Thomson Reuters StreetEvents
May-09-18 01:45PM  Here's Why Cerus Corporation Stock Is Surging Today Motley Fool +14.99%
May-08-18 05:25PM  Cerus: 1Q Earnings Snapshot Associated Press
04:03PM  Cerus Corporation Reports First Quarter 2018 Results Business Wire
May-03-18 08:30AM  Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018 Business Wire
Apr-25-18 08:30AM  Cerus to Release First Quarter 2018 Results on May 8, 2018 Business Wire
08:30AM  Cerus Announces Health Canada Approval of the INTERCEPT Blood System for Platelets Business Wire
Apr-02-18 08:30AM  Cerus RedeS Phase 3 Red Blood Cell Study Expands Into the Continental U.S. Business Wire
Mar-28-18 03:39PM  Blood transfusion company inks deal for new East Bay headquarters American City Business Journals
Mar-22-18 08:15AM  Cerus Corporation, Shares Up 39% in the Past Month, Analysts Review, INTERCEPT ACCESSWIRE
Mar-19-18 08:36AM  Cerus (CERS) Looks Good: Stock Adds 9.5% in Session Zacks
Mar-16-18 07:10AM  Wired News FDA Accepted Tymes IND Application to Begin Phase-II Clinical Study for SM-88 in Pancreatic Cancer ACCESSWIRE +9.54%
Mar-14-18 07:10PM  Is Cerus Corporations (NASDAQ:CERS) Balance Sheet A Threat To Its Future? Simply Wall St. +5.65%
Mar-13-18 07:30AM  Cerus Announces the Fourth Biologics License Application (BLA) Approval for a U.S. Blood Center Customer Business Wire
Mar-09-18 04:06PM  Edited Transcript of CERS earnings conference call or presentation 8-Mar-18 9:15pm GMT Thomson Reuters StreetEvents
Mar-08-18 04:37PM  Cerus reports 4Q loss Associated Press
04:03PM  Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results Business Wire
12:00PM  Cerus Corporation to Host Earnings Call ACCESSWIRE
Mar-07-18 08:30AM  Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018 Business Wire
Mar-01-18 02:47PM  Should You Be Holding Cerus Energy Group Ltd (CVE:CEA) Right Now? Simply Wall St.
Feb-22-18 08:30AM  Cerus to Release Fourth Quarter and Year End 2017 Results on March 8, 2018 Business Wire
Feb-13-18 07:40AM  Detailed Research: Economic Perspectives on REV Group, CoreLogic, Nu Skin Enterprises, Torchmark, Evertec, and Cerus What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-02-18 04:15PM  Cerus Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares Business Wire
Jan-31-18 09:00AM  Cerus Announces Pricing of Public Offering of Common Stock Business Wire -6.93%
Jan-30-18 04:13PM  Cerus Announces Public Offering of Common Stock Business Wire
Jan-25-18 08:54AM  Cerus, Pfizer Both Just Put Out Key Late Stage Data Market Exclusive
08:10AM  Todays Research Reports on Stocks to Watch: Cerus Corporation and Halozyme Therapeutics ACCESSWIRE
Jan-24-18 02:46PM  Cerus shares rise on positive late-stage results for anemia therapy MarketWatch +15.70%
12:34PM  Here's Why Cerus Corporation Stock Popped Today Motley Fool
08:26AM  Benzinga Pro's 6 Stocks To Watch Today Benzinga
Jan-23-18 04:15PM  Cerus Reports Positive Top-Line Results from Chronic Anemia Phase 3 Study Evaluating INTERCEPT Red Blood Cells in Thalassemia Patients Business Wire
Jan-08-18 08:30AM  Cerus Corporation Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017 Business Wire +10.42%
Jan-03-18 10:28AM  Should You Buy Cerus Corporation (NASDAQ:CERS) At $3.56? Simply Wall St.
Dec-28-17 07:39AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : December 28, 2017 Capital Cube
Dec-27-17 11:05AM  ETFs with exposure to Cerus Corp. : December 27, 2017 Capital Cube
09:49AM  Universal Health Grows Inorganically, Rising Costs a Drag Zacks
Dec-26-17 08:57AM  Cerus Corp. :CERS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017 Capital Cube
Dec-19-17 02:57PM  Should You Invest In The Oil & Gas Stock Cerus Energy Group Ltd (CVE:CEA)? Simply Wall St.
Dec-12-17 12:26PM  Does Cerus Energy Group Ltds (CVE:CEA) Recent Track Record Look Strong? Simply Wall St.
Nov-22-17 08:10AM  Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus New Research Emphasizes Economic Growth GlobeNewswire
Nov-17-17 03:12PM  Who Are The Largest Shareholders In Cerus Energy Group Ltd (TSXV:CEA)? Simply Wall St.
Nov-15-17 09:38AM  Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy Zacks
Nov-14-17 09:16AM  5 Breakout Stocks Offering Admirable Returns Zacks
Nov-07-17 06:35PM  Edited Transcript of CERS earnings conference call or presentation 2-Nov-17 8:15pm GMT Thomson Reuters StreetEvents
08:30AM  Cerus Corporation Receives IDE Approval to Initiate Phase III ReCePI Study Business Wire
Nov-03-17 01:31PM  Here's Why Cerus Corporation Rose as Much as 23.6% Today Motley Fool +22.22%
Nov-02-17 05:19PM  Cerus reports 3Q loss Associated Press
04:01PM  Cerus Corporation Reports Third Quarter 2017 Results Business Wire
Nov-01-17 04:55PM  Should You Be Concerned About Cerus Energy Group Ltds (TSXV:CEA) Risks? Simply Wall St.
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company's INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation was founded in 1991 and is headquartered in Concord, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green Kevin DennisChief Financial OfficerFeb 11Option Exercise2.152,7835,98363,608Feb 12 05:19 PM
Green Kevin DennisChief Financial OfficerFeb 11Sale5.862,78316,31360,825Feb 12 05:19 PM
Green Kevin DennisChief Financial OfficerJan 10Option Exercise2.152,7835,98363,608Jan 11 05:31 PM
Green Kevin DennisChief Financial OfficerJan 10Sale5.592,78315,56360,825Jan 11 05:31 PM
Greenman William MarinerPresident and CEODec 28Option Exercise0.79150,000118,500549,601Dec 31 04:01 PM
Green Kevin DennisChief Financial OfficerDec 10Option Exercise2.152,7835,98363,608Dec 11 05:25 PM
Green Kevin DennisChief Financial OfficerDec 10Sale5.352,78314,88960,825Dec 11 05:25 PM
Green Kevin DennisChief Financial OfficerNov 12Option Exercise2.152,7835,98363,608Nov 13 07:05 PM
Green Kevin DennisChief Financial OfficerNov 12Sale5.562,78315,47260,825Nov 13 07:05 PM
Green Kevin DennisChief Financial OfficerOct 10Option Exercise2.152,7835,98363,608Oct 11 06:47 PM
Green Kevin DennisChief Financial OfficerOct 10Sale6.092,78316,94660,825Oct 11 06:47 PM
Greenman William MarinerPresident and CEOSep 27Option Exercise4.1940,000167,600399,601Oct 01 12:00 AM
Green Kevin DennisChief Financial OfficerSep 10Option Exercise2.152,7835,98363,608Sep 10 07:46 PM
Green Kevin DennisChief Financial OfficerSep 10Sale7.242,78320,14160,825Sep 10 07:46 PM
Benjamin Richard JChief Medical OfficerAug 28Option Exercise4.7250,000236,00050,000Aug 30 07:40 PM
Green Kevin DennisChief Financial OfficerAug 28Option Exercise3.0050,000150,000110,825Aug 29 07:13 PM
Benjamin Richard JChief Medical OfficerAug 28Sale7.5250,000376,0550Aug 30 07:40 PM
Green Kevin DennisChief Financial OfficerAug 28Sale7.5050,000375,00560,825Aug 29 07:13 PM
Benjamin Richard JChief Medical OfficerAug 14Option Exercise4.3335,416153,35135,416Aug 16 06:06 PM
Green Kevin DennisChief Financial OfficerAug 10Option Exercise2.162,7836,00063,558Aug 14 01:23 PM
Green Kevin DennisChief Financial OfficerAug 10Sale6.962,78319,37260,825Aug 14 01:23 PM
CORASH LAURENCE MChief Scientific OfficerJul 25Option Exercise4.1935,000146,6501,637,591Jul 26 07:56 PM
SCHULZE GAILDirectorJun 08Option Exercise0.8052,50041,92563,486Jun 12 05:40 PM
SCHULZE GAILDirectorJun 08Sale6.6552,500349,12525,986Jun 12 05:40 PM
Moore CarolSVP Reg. & QualityJun 05Option Exercise0.7969,47854,888110,319Jun 06 05:50 PM
Moore CarolSVP Reg. & QualityJun 05Sale6.7269,478467,08040,841Jun 06 05:50 PM
Moore CarolSVP Reg. & QualityJun 04Option Exercise0.795,5224,36246,363Jun 06 05:50 PM
Moore CarolSVP Reg. & QualityJun 04Sale6.705,52236,99740,841Jun 06 05:50 PM
ANDERSON TIMOTHY BDirectorMay 18Option Exercise3.0350,000151,250144,573May 30 06:55 PM
ANDERSON TIMOTHY BDirectorMay 18Sale6.6523,000152,950119,573May 30 06:55 PM
Green Kevin DennisChief Financial OfficerMay 17Option Exercise1.0529,70031,18590,525May 18 04:34 PM
Green Kevin DennisChief Financial OfficerMay 17Sale6.4729,700192,08860,825May 18 04:34 PM
Green Kevin DennisChief Financial OfficerMay 16Option Exercise0.9143,30039,485104,125May 18 04:34 PM
Green Kevin DennisChief Financial OfficerMay 16Sale6.3943,300276,73560,825May 18 04:34 PM
Moore CarolSVP Reg. & QualityMay 11Option Exercise4.1920,00083,80060,841May 14 07:32 PM
Moore CarolSVP Reg. & QualityMay 11Sale6.2660,841380,8650May 14 07:32 PM
Benjamin Richard JChief Medical OfficerMay 11Sale6.698,63157,7220May 14 07:31 PM
CORASH LAURENCE MChief Scientific OfficerMar 15Buy5.2732,100169,2831,602,591Mar 15 05:25 PM
CORASH LAURENCE MChief Scientific OfficerMar 14Buy5.1917,91192,9581,570,491Mar 15 05:25 PM
CORASH LAURENCE MChief Scientific OfficerMar 13Buy5.1390,000461,4751,552,580Mar 15 05:25 PM
Menard ChrystalChief Legal OfficerMar 13Sale5.052,65013,38325,628Mar 13 09:26 PM
Moore CarolSVP Reg. & QualityMar 13Sale5.052,62313,24640,841Mar 13 09:25 PM
Greenman William MarinerPresident and CEOMar 13Sale5.0510,03150,657354,779Mar 13 09:28 PM
Green Kevin DennisChief Financial OfficerMar 13Sale5.052,67413,50460,825Mar 13 09:27 PM
Benjamin Richard JChief Medical OfficerMar 13Sale5.052,64813,3728,652Mar 13 09:23 PM
CORASH LAURENCE MChief Scientific OfficerMar 12Buy4.9510,00049,4831,462,580Mar 15 05:25 PM
Benjamin Richard JChief Medical OfficerMar 12Sale4.801,0324,9553,800Mar 13 09:23 PM
Greenman William MarinerPresident and CEOMar 12Sale4.807,73537,138336,685Mar 13 09:28 PM
Menard ChrystalChief Legal OfficerMar 12Sale4.801,9609,41111,095Mar 13 09:26 PM
Moore CarolSVP Reg. & QualityMar 12Sale4.802,0639,90535,964Mar 13 09:25 PM
Green Kevin DennisChief Financial OfficerMar 12Sale4.802,0639,90555,999Mar 13 09:27 PM